explore -WSS

explore

author：leisure time 2025-10-02 11:18:45 - browse：8258

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： A controversial new treatment promises to make little people taller

leisure time

WSS

Measles policy set amid Florida outbreak alarms vaccine proponents

The cancer stories no one wants to hear

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Researchers tackle phage therapy hurdles for wider adoption

Flagship Pioneering startup Sonata Therapeutics lays off 21

focus

explore

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

2 officers injured in shooting in Orlando, police say

Dobbs anniversary: the lost opportunity of abortion as health care

Flint parents haunted by uncertainty, fears of lead poisoning

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A controversial new treatment promises to make little people taller

Peter Hotez and the public health issue of online harassment

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Cancer drug shortages should be causing more outrage

New study raises questions about niacin and heart health

hotspot

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Secretariat’s lessons for human medicine

The cancer stories no one wants to hear

Opioid cravings were reduced by anti

How I helped Pfizer think through the ethics of Viagra

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

leisure time

focus

leisure time

focus